These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 370089)

  • 21. Genetic study of plasmid-associated zonal resistance to lincomycin in Streptococcus pyogenes.
    Malke H; Reichardt W; Hartmann M; Walter F
    Antimicrob Agents Chemother; 1981 Jan; 19(1):91-100. PubMed ID: 7018388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
    Marks MI
    Can Med Assoc J; 1975 Jan; 112(2):170-3. PubMed ID: 234287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of protease in streptolysin S formation.
    Akao T; Akao T; Kobashi K; Lai CY
    Arch Biochem Biophys; 1983 Jun; 223(2):556-61. PubMed ID: 6344797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group A streptococci resistant to erythromycin & lincomycin.
    Prakash K; Chattopadhya D
    Indian J Med Res; 1988 Nov; 88():391-4. PubMed ID: 3058591
    [No Abstract]   [Full Text] [Related]  

  • 25. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
    Sutcliffe J; Tait-Kamradt A; Wondrack L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferable lincosamide-macrolide resistance in Bacteroides.
    Welch RA; Jones KR; Macrina FL
    Plasmid; 1979 Apr; 2(2):261-8. PubMed ID: 451051
    [No Abstract]   [Full Text] [Related]  

  • 27. Penicillin and clindamycin alter some group A streptococcal products.
    Figueiredo AM; Benchetrit LC
    Zentralbl Bakteriol; 1989 Oct; 271(4):475-80. PubMed ID: 2684207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.
    Dixon JM; Lipinski AE
    J Infect Dis; 1974 Oct; 130(4):351-6. PubMed ID: 4613758
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of the physico-chemical parameters of Streptococcus pyogenes cultures on the formation of O-streptolysin. II. The role of reducing agents in the formation of O-streptolysin.
    Füvessy I; Böszörményi J; Veress A
    Acta Microbiol Acad Sci Hung; 1967; 24(4):335-43. PubMed ID: 4870930
    [No Abstract]   [Full Text] [Related]  

  • 30. The essential factor for streptolysin S production by Streptococcus pyogenes.
    Akao T; Tamei H; Kobashi K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):3994-9. PubMed ID: 3073020
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetics of resistance to macrolide antibiotics and lincomycin in natural isolates of Streptococcus pyogenes.
    Malke H
    Mol Gen Genet; 1974; 135(4):349-67. PubMed ID: 4618889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugative R plasmids in Streptococcus agalactiae (group B).
    Horodniceanu T; Bougueleret L; El-Solh N; Bouanchaud DH; Chabbert YA
    Plasmid; 1979 Apr; 2(2):197-206. PubMed ID: 109871
    [No Abstract]   [Full Text] [Related]  

  • 33. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
    Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
    Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
    [No Abstract]   [Full Text] [Related]  

  • 34. Lincosamide antibiotics stimulate dissociation of peptidyl-tRNA from ribosomes.
    Menninger JR; Coleman RA
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2027-9. PubMed ID: 8239627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical microbiology of lincomycin antibiotics].
    Modde H
    Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with maximal tolerated doses of antibiotics. II. Chloramphenicol, lincomycin, and other preparations].
    Vacek V; Hejzlar M; Stafová J
    Cas Lek Cesk; 1968; 107(44):1316-9. PubMed ID: 4971814
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro antibiotic sensitivity of Pasteurella multocida.
    Rosenthal SL; Freundlich LF
    Health Lab Sci; 1976 Oct; 13(4):246-9. PubMed ID: 977341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections.
    Savage GM
    Infection; 1974; 2(3):152-9. PubMed ID: 4606764
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitivities of clinical isolates to lincomycin and macrolide-type antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1981 Mar; 34(3):419-24. PubMed ID: 7289033
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.
    Dixon JM; Lipinski AE
    Antimicrob Agents Chemother; 1972 Apr; 1(4):333-9. PubMed ID: 4598840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.